OR WAIT null SECS
August 13, 2021
Rentschler Biopharma has broken ground nearby its Milford, Mass., site where it will build its new multi-product manufacturing facility for commercial production of complex molecules.
August 12, 2021
The Just - Evotec Biologics facility in Redmond, Wash., uses the company’s J.POD technology.
August 03, 2021
Controlling conditions and preventing contamination are crucial for cell growth.
July 22, 2021
Catalent commences the first phase of a $100-million expansion program Anagni site to increase its manufacturing capabilities for biologics drug substance.
July 13, 2021
GEA’s plug-and-produce skids are designed for multi-product pharmaceutical and biopharmaceutical separation.
NewAge Industries is adding cleanrooms at its Pennsylvania headquarters.
June 16, 2021
Yposkesi is building its second commercial facility for cell and gene therapy manufacturing at its campus on Corbeil-Essonnes, France.
Optima has teamed up with the Robert-Bosch-Krankenhaus and Heidelberg University to develop a unit for decentralized, automated production of CAR-T cell therapies.
June 08, 2021
VIVEbiotech has opened its new lentiviral vector manufacturing facilities in Spain, expanding capacity for lentiviral vectors for use in cell and gene therapies.
June 03, 2021
The emergence of new biotherapeutics is both the driver and result of innovative drug development technologies.